RAP-219: Clinical Trials

2 trials of RAP-219, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Recruiting 2

Follow RAP-219: new trials by email Literature Review of RAP-219 trials Research Report on RAP-219

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
RAP-219, Placebo - Focal Seizure, Epilepsy
Phase 3RecruitingRapport Therapeutics Inc.3122026-09-012026-11-06
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
RAP-219, Placebo - Focal Seizure, Epilepsy
Phase 3RecruitingRapport Therapeutics Inc.3332026-06-052026-11-06

Conditions studied

Epilepsies, Partial (2)  ·  Epilepsy (2)  ·  Seizures (2)

Sponsors

Rapport Therapeutics Inc. (2)

Countries

Australia (2)  ·  United States (2)  ·  South Korea (1)  ·  United Kingdom (1)

Top investigators

Vicente Villaneuva, M.D., PhD (1)